Search Results - "Jentzmik, F"

Refine Results
  1. 1
  2. 2

    Recent Therapy of Organ-confined Testis Cancer by Breunig, C, Zengerling, F, Schnöller, T, Schrader, M, Jentzmik, F

    Published in Aktuelle Urologie (01-04-2016)
    “…In Germany, testicular cancer accounts for about 1-2% of all malignant tumours. Although, therefore, this is a rare tumour, it assumes an exceptional position…”
    Get more information
    Journal Article
  3. 3

    Diagnostic relevance of choline-PET / CT in patients with prostate cancer by Zengerling, F, Schrader, A J, Schrader, M, Jentzmik, F

    Published in Aktuelle Urologie (01-01-2012)
    “…The choline-positron emissiontomography / computed tomography (choline-PET / CT) is a widely used imaging method for prostate cancer. This review concentrates…”
    Get more information
    Journal Article
  4. 4

    Benefits and risks of orthotopic neobladder reconstruction in female patients by Gakis, G, Jentzmik, F, Schrader, M, Stenzl, A, Sievert, K-D

    Published in Aktuelle Urologie (01-03-2011)
    “…Orthotopic neobladder reconstruction is an established treatment option in female patients undergoing radical cystectomy for invasive bladder cancer. Long-term…”
    Get more information
    Journal Article
  5. 5

    Chirurgie des lokalisierten Nierenzellkarzinoms by Schnöller, T.J., Schrader, M., Jentzmik, F.

    Published in Der Onkologe (2015)
    “…Zusammenfassung Hintergrund Das Nierenzellkarzinom ist in Deutschland die dritthäufigste maligne urologische Erkrankung. Die Inzidenz nimmt tendenziell zu und…”
    Get full text
    Journal Article
  6. 6

    Palliative care and medicamentous therapy during the final episode of life by Schnoeller, T J, Ghazal, A Al, Jentzmik, F, Mueller, J, Schrader, M, Schrader, A J

    Published in Aktuelle Urologie (01-12-2012)
    “…The idea of modern palliative care goes back to the times of Dame Cicely Mary Strode Saunders in 1967, a British nurse and physician. Modern palliative care is…”
    Get more information
    Journal Article
  7. 7

    Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents by Lingnau, Anja, Miller, K, Steiner, U, Jentzmik, F, Weikert, S, Schostak, M

    Published in Aktuelle Urologie (01-09-2009)
    “…The aim of this questionnaire was to obtain an impression of the practice and applied therapeutic agents in postoperative and adjuvant intravesical therapy of…”
    Get more information
    Journal Article
  8. 8

    New biomarkers and application of multivariate models for detection of prostate cancer by Stephan, C, Cammann, H, Rittenhouse, H, Lein, M, Jentzmik, F, Schrader, M, Deger, S, Miller, K, Jung, K

    Published in Aktuelle Urologie (01-08-2009)
    “…The specificity of PSA has been enhanced by using molecular forms of PSA and free PSA (fPSA) such as percent free PSA (%fPSA), proPSA, intact PSA or BPHA and /…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Secondary prevention in patients with superficial urothelial carcinoma by Schnöller, T J, Zengerling, F, Hirning, C, Jentzmik, F

    Published in Urologe. Ausgabe A (01-07-2015)
    “…Urothelial cancer is the 4th most common cancer in men and the 7th most common malignancy in women in Germany. 95 % of all tumors of the urinary bladder are…”
    Get full text
    Journal Article
  11. 11

    Management of muscle-invasive bladder cancer by Mueller, J, Schrader, A J, Schrader, M, Schnoeller, T, Jentzmik, F

    Published in Italian journal of urology and nephrology (01-12-2013)
    “…The incidence of muscle-invasive bladder cancer (MIBC) is increasing. Many different and multimodal novel treatment options were brought on the way since the…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results by Jentzmik, F, Schrader, M, de Petriconi, R, Hefty, R, Doetterl, J, Eickhoff, A, Schrader, A J

    Published in Urologe. Ausgabe A (01-10-2012)
    “…As life expectancy is increasing the incidence and therefore the number of elderly female patients with bladder cancer is also increasing. The aim of this…”
    Get full text
    Journal Article
  14. 14

    Sekundäre Prävention bei Patienten mit oberflächlichem Urothelkarzinom by Schnöller, T.J., Zengerling, F., Hirning, C., Jentzmik, F.

    Published in Urologe. Ausgabe A (01-07-2015)
    “…Zusammenfassung Hintergrund Das Urothelkarzinom ist bei Männern die vierthäufigste und bei Frauen die siebthäufigste maligne Erkrankung in Deutschland. 95 %…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Renal masses in pregnancy. Diagnostics and therapeutic management by Schnöller, T J, Jentzmik, F, Al Ghazal, A, Zengerling, F, de Petriconi, R, Hefty, R, Rinnab, L, Schrader, M, Schrader, A J

    Published in Urologe. Ausgabe A (01-09-2011)
    “…Cancer is the second most common cause of death in women of childbearing age. However, renal cell carcinoma (RCC) is a rare tumor in this collective with an…”
    Get full text
    Journal Article
  17. 17

    Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer by Waalkes, S, Eggers, H, Rustemeier, J, Wegener, G, Jentzmik, F, Schrader, M, Hofmann, R, Kuczyk, M A, Schrader, A J

    Published in Urologe. Ausgabe A (01-09-2011)
    “…Obesity increases the risk of developing renal cell carcinoma (RCC). We assessed whether different body mass index (BMI) levels and the body surface area (BSA)…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Zystektomie mit Anlage einer Ileumneoblase bei der über 70-jährigen Frau: Morbidität, funktionelle und onkologische Ergebnisse by Jentzmik, F., Schrader, M., de Petriconi, R., Hefty, R., Doetterl, J., Eickhoff, A., Schrader, A.J.

    Published in Urologe. Ausgabe A (01-10-2012)
    “…Zusammenfassung Hintergrund und Fragestellung Im Zuge der demographischen Entwicklung steigt die Inzidenz und damit der Anteil an älteren Patientinnen, die am…”
    Get full text
    Journal Article
  20. 20

    Übergewicht ist ein günstiger Prognosefaktor für Patienten mit Nierenzellkarzinom by Waalkes, S., Eggers, H., Rustemeier, J., Wegener, G., Jentzmik, F., Schrader, M., Hofmann, R., Kuczyk, M.A., Schrader, A.J.

    Published in Urologe. Ausgabe A (01-09-2011)
    “…Zusammenfassung Hintergrund und Fragestellung Mehrere große internationale Studien identifizierten Übergewicht als Risikofaktor für die Entstehung eines…”
    Get full text
    Journal Article